Viemed Healthcare, Inc. (NASDAQ:VMD) Director Sells 8,852 Shares

Viemed Healthcare, Inc. (NASDAQ:VMD - Get Free Report) Director Nitin Kaushal sold 8,852 shares of the firm's stock in a transaction that occurred on Thursday, June 26th. The shares were sold at an average price of $7.00, for a total transaction of $61,964.00. Following the completion of the transaction, the director owned 126,843 shares in the company, valued at $887,901. The trade was a 6.52% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website.

Nitin Kaushal also recently made the following trade(s):

• On Friday, June 27th, Nitin Kaushal sold 34,100 shares of Viemed Healthcare stock. The stock was sold at an average price of $7.01, for a total transaction of $239,041.00.

Viemed Healthcare Trading Up 0.6%

Shares of VMD stock traded up $0.05 during mid-day trading on Wednesday, reaching $7.05. The company's stock had a trading volume of 88,108 shares, compared to its average volume of 144,054. The company has a quick ratio of 1.26, a current ratio of 1.38 and a debt-to-equity ratio of 0.03. The firm has a market capitalization of $278.42 million, a PE ratio of 23.58 and a beta of 1.37. The company's 50 day simple moving average is $6.79 and its 200-day simple moving average is $7.37. Viemed Healthcare, Inc. has a 12-month low of $6.14 and a 12-month high of $9.81.

Viemed Healthcare (NASDAQ:VMD - Get Free Report) last released its quarterly earnings data on Wednesday, May 7th. The company reported $0.06 EPS for the quarter, meeting the consensus estimate of $0.06. The company had revenue of $59.10 million for the quarter, compared to analyst estimates of $60.60 million. Viemed Healthcare had a return on equity of 9.49% and a net margin of 5.28%.

Institutional Investors Weigh In On Viemed Healthcare

Several hedge funds have recently modified their holdings of VMD. Millennium Management LLC purchased a new stake in Viemed Healthcare during the 4th quarter worth $573,000. Ameriprise Financial Inc. purchased a new stake in shares of Viemed Healthcare during the fourth quarter worth about $340,000. Nuveen Asset Management LLC lifted its stake in shares of Viemed Healthcare by 22.1% in the fourth quarter. Nuveen Asset Management LLC now owns 162,272 shares of the company's stock worth $1,301,000 after acquiring an additional 29,320 shares in the last quarter. Rhumbline Advisers lifted its stake in shares of Viemed Healthcare by 15.5% in the fourth quarter. Rhumbline Advisers now owns 46,836 shares of the company's stock worth $376,000 after acquiring an additional 6,275 shares in the last quarter. Finally, Arrowstreet Capital Limited Partnership purchased a new position in Viemed Healthcare in the fourth quarter valued at about $1,549,000. 74.24% of the stock is currently owned by hedge funds and other institutional investors.

About Viemed Healthcare

Viemed Healthcare, Inc, together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD.